key: cord-0896805-9yzxpp0d authors: Akpoji, Ukwen; Amos, Mary Ellen; McMillan, Katelyn; Sims, Sharanie; Rife, Kelsey title: Exercising Empathy: Pharmacists Possess Skills to Increase Coronavirus Vaccine Confidence date: 2021-07-30 journal: J Am Pharm Assoc (2003) DOI: 10.1016/j.japh.2021.07.016 sha: a8529b2a0a2c095d2c8374eb59bee7b9a129c3d9 doc_id: 896805 cord_uid: 9yzxpp0d The 2019 coronavirus disease (COVID-19) vaccines are the essential public health intervention to confer SARS-CoV-2 immunity, while decreasing the risks of severe COVID-19 disease, hospitalizations, and death associated with natural infection. Public health experts agree that the public health interventions of social distancing and face coverings will only be able to successfully curtail the COVID-19 pandemic in the U.S. when combined with the highly effective COVID-19 vaccines. The risk for severe COVID-19 is higher in Americans with highly prevalent metabolic and cardiovascular chronic conditions as well as vulnerable demographics, such as minorities and pregnant women. Unfortunately, experience with past unethical health practices can influence current vaccine confidence in people of color and women of childbearing age. Pharmacists are well-positioned in myriad health care settings across the nation to listen to these concerns and have the conversations necessary to increase vaccine confidence. Similar to effective roles pharmacists have had in other health prevention efforts like smoking cessation, pharmacists possess the motivational interviewing skills to guide patients from the “pre-contemplation” to the “action” stages of health behavior change. This nonjudgmental, mutual understanding will help identify the individual factors influencing vaccine decision-making and bring us closer to achieving “community immunity.” The 2019 coronavirus disease vaccines are the essential public health intervention to confer 2 SARS-CoV-2 immunity, while decreasing the risks of severe COVID-19 disease, hospitalizations, and 3 death associated with natural infection. Public health experts agree that the public health interventions 4 of social distancing and face coverings will only be able to successfully curtail the COVID-19 pandemic in 5 the U.S. when combined with the highly effective COVID-19 vaccines. The risk for severe COVID-19 is 6 higher in Americans with highly prevalent metabolic and cardiovascular chronic conditions as well as 7 vulnerable demographics, such as minorities and pregnant women. Unfortunately, experience with past 8 unethical health practices can influence current vaccine confidence in people of color and women of 9 childbearing age. Pharmacists are well-positioned in myriad health care settings across the nation to 10 listen to these concerns and have the conversations necessary to increase vaccine confidence. Similar to 11 effective roles pharmacists have had in other health prevention efforts like smoking cessation, 12 pharmacists possess the motivational interviewing skills to guide patients from the "pre-contemplation" 13 to the "action" stages of health behavior change. This nonjudgmental, mutual understanding will help 14 identify the individual factors influencing vaccine decision-making and bring us closer to achieving 15 "community immunity." 16 Commentary 20 As of May 2021, COVID-19 has infected approximately 160 million people worldwide and 33 million 21 Americans. COVID-19 has taken the lives of 3.3 million people worldwide and 582,848 Americans. 1 While 22 the novel SARS-CoV-2 coronavirus has upended a sense of "normalcy" for all humans worldwide, it has 23 highlighted health disparities for vulnerable populations by exploiting the inadequacies in our healthcare 24 infrastructure. Globally, the United States (U.S.) consistently has poorer health outcomes and wider 25 health disparities despite higher healthcare spending per capita. Among wealthy nations, the U.S. has 26 the highest rates of chronic disease burden, defined as adults with two or more of the following: joint 27 pain/arthritis, asthma or chronic lung disease, diabetes, heart disease, or hypertension. Many of these 28 same chronic disease states parallel the risk factors influencing morbidity and mortality of severe 29 COVID-19 disease in Americans. 2,3 Similarly, women in the U.S. are more likely to die during pregnancy 30 or childbirth compared to other wealthy nations, likely due to poorer access to prenatal care, higher 31 rates of caesarean deliveries, and higher rates of obesity, heart disease, and diabetes. 4 This is 32 compounded by COVID-19, as pregnant individuals infected with COVID-19 are not only at increased risk 33 of severe disease compared to non-pregnant women but also at increased risk of untoward pregnancy 34 outcomes. 5 Disproportionate risk of severe COVID-19 infection in minority communities and/or pregnant 35 women combined with the apprehension of receiving a COVID-19 vaccine in these same demographics 36 are widening the extant gap on COVID-19 morbidity and mortality in these populations (Figures 1 and 37 2). One in four Americans do not want to receive a COVID-19 vaccine, including healthcare workers. 6-8 It 38 is estimated that at least 7 in 10 Americans need to be vaccinated to achieve "community immunity" 39 from COVID-19 and put an end to this pandemic. 9 40 To increase "community immunity" and decrease the infection risk from more transmissible COVID-41 19 variants, factors associated with vaccine hesitancy need to be addressed. Reasons for vaccine 42 hesitancy can vary from personal experiences (e.g., mistrust, safety, trypanophobia) to general 43 J o u r n a l P r e -p r o o f concerns about vaccine data (e.g., accelerated vaccine development). To break the cycle of health 44 inequity resulting from COVID-19, the underlying concerns of vulnerable communities and how those 45 concerns contribute to their healthcare experiences, affecting their general trust in medical care and 46 vaccine confidence, must be understood and rectified. The following factors influencing vaccine 47 confidence among minority and pregnant Americans have been identified: 48 This pandemic has exposed American healthcare discrepancies for racial minorities, but the lack of 50 engagement with healthcare and clinical research is rooted in the history of unethical medical practices 51 since the 19 th century. 10 In the 1840s, Dr. Marion Sims performed innumerable vaginal fistula surgeries 52 on enslaved, African-American women without anesthesia. He did not obtain informed consent, since 53 these women were considered "property" and not "free" to have a choice. 11 In 1932, the "Tuskegee 54 Study of Untreated Syphilis in the Negro Male" followed 600 Black men with and without syphilis who 55 were enrolled without informed consent. During the 40-year study, penicillin was available beginning in 56 1941 and -though it remains the preferred syphilis treatment today -none of the 399 participants with 57 syphilis were offered treatment. 12 More recently in the 1990s, the Johns Hopkins Kennedy Krieger 58 Institute studied lead exposures in 108 African-American children to find cost-effective means for 59 childhood lead exposure reduction. The most ethical intervention would have been to eliminate lead 60 exposure risk from homes, but that was considered too costly. Families were instead given incremental 61 monetary abatements to live in homes with increased lead levels during the multi-year study. 13 62 Unfortunately, this mistrust is not limited to the Black community; American Indian and LatinX 63 communities have also been affected by unprotected radiation exposure as well as fear of deportation 64 when seeking medical care. Navajo miners were tasked to mine uranium in the Southwestern U.S. in the 65 mid-20 th century. Despite the known lung cancer risks of uranium and radon exposure, there were 66 minimal protections offered to the Navajo people. It was not until 1990 that the "Radiation Exposure 67 J o u r n a l P r e -p r o o f Compensation Act (RECA)" was passed for reparations. 14 Furthermore, immigrant families are often less 68 likely to engage in healthcare due to fear of deportation; rates of uninsured LatinX children via 69 governmental health insurance programs increased from 7.7 to 8.1% between 2016 and 2018. 15 70 Unfortunately, these concerns reportedly increase toxic stress levels for both parents and children, 71 according to pediatricians, and exacerbate the poorer health outcomes in LatinX communities. 16 72 These experiences are just snapshots in the long history of questionable experimentation, 73 inadequate protections, and medical unease in minority communities. In addition to these egregious 74 events, individuals in communities of color still report experiencing unconscious bias during health care 75 encounters as well as unequal access to basic health care measures like vaccines. [17] [18] [19] Racial disparities in 76 pain management, for example, still exist in the 21 st century, where medical trainees inappropriately 77 believe that Black patients have "thicker skin" and higher pain tolerance than White patients. 20 78 Therefore, pharmacists need to make deliberate efforts to address their unconscious bias, as this along 79 with minority mistrust can influence decisions to receive a COVID-19 vaccine 21 and engage with the 80 healthcare system at-large. 81 Historically, government has not prioritized women's health autonomy and the aforementioned 83 mistrust is amplified in minority women. In the LatinX communities, U.S. laws disproportionately 84 treatments in pregnancy as well as in women of childbearing age will help identify opportunities to 120 understand the individual perspectives of each birth experience and determine which factors may be 121 most influential regarding prenatal and fertility medical decision-making. 122 Pharmacists may not only have the task of reassuring their patients but also reassuring themselves 124 about the COVID-19 vaccine, as some could be reconciling their own minority and/or childbearing 125 concerns. This progression often does not take a single conversation but occurs over a continuum of 126 change. Pharmacists are accessible, trusted, healthcare workers who are knowledgeable about vaccines 127 and able to translate health information into patient-comprehensible language. Thus, they are well-128 positioned to engage in these series of conversations necessary to increase vaccine confidence. As with 129 smoking cessation counseling, pharmacists can gauge patients' readiness for change (e.g., vaccine 130 uptake). Whether patients are in the "precontemplation" or "action" stages of change, pharmacists can 131 employ motivational interviewing to guide our patients throughout their vaccine confidence journey. 35 COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins 165 University health care from a global perspective, 2019: higher spending, worse 169 outcomes? Commonw Fund Health rankings What is the status of women's health and health care 173 in the U.S. Compared to ten other countries? Commonw Fund Investigating the Impact of COVID-19 during 176 Pregnancy COVID-19 Vaccine Hesitancy | Home of the Marist Poll Vaccine hesitancy: the next challenge in the fight against 182 COVID-19 Vaccine hesitancy and 184 healthcare providers More than Tuskegee: 189 understanding mistrust about research participation. J Health Care Poor Underserved Appleton and 192 company; 1884 With the best intentions lead research and the challenge to public health The history of uranium mining and the Navajo people Decade of success for Latino children's health now in 200 jeopardy Living in an immigrant family in America: how fear and toxic stress are affecting 203 daily life, well-being, & health. Kais Fam Found Implicit bias in healthcare professionals: a systematic review The impact of unconscious bias in 207 healthcare: how to recognize and mitigate it How unconscious bias can discriminate against patients and affect their care Racial bias in pain assessment and treatment 212 recommendations, and false beliefs about biological differences between Blacks and Whites Racial and ethnic differences in COVID-19 vaccine hesitancy 215 and uptake. medRxiv Sterilization regret among Puerto Rican women Disproportionate sterilization of 221 Latinos under California's eugenic sterilization program, 1920-1945 Sterilization and social welfare Against their will: North Carolina's sterilization program and 225 the campaign for reparations. Gray Oak Books Characteristics and maternal and birth outcomes of hospitalized pregnant women 227 with laboratory-confirmed COVID-19 -COVID-NET, 13 States Maternal mortality and maternity care in the 242 United States compared to 10 other developed countries. Commonw Fund Fact check: A false post on social media claims COVID-19 vaccine causes infertility in 245 women Influenza and Tdap vaccination coverage among pregnant women -United States Smoking cessation: Identifying readiness to quit and designing a plan The transtheoretical model of health behavior change Conversation guide to improve covid-19 vaccine uptake | IHI -Institute 255 for Healthcare Improvement Addressing vaccine hesitancy in the pharmacy A three-tiered approach to address barriers to COVID-259 19 vaccine delivery in the Black community COVID-19 vaccine response in pregnant and lactating women: a 262 cohort study Preliminary findings of mRNA COVID-19 vaccine safety in 264 pregnant persons Strategies for responding to vaccine hesitancy and vaccine deniers % US Population in Demographic % Infections (n = 92,763) % Live Births #vaccination-demographic United States of America Census Data. United States Census Bureau